NPR's Melissa Block talks to Dr. Marilyn Albert, professor of neurology and director of the Division of Cognitive Neuroscience at Johns Hopkins, about the latest in treating and diagnosing Alzheimer's disease. Albert says she and her colleagues are disappointed that Eli Lilly stopped its clinical trials of an experimental treatment, but that many other drugs are currently in development. While no one expects any of those to be a cure, the hope is that there will be a drug to delay the progression of the disease.
The Latest In Treating, Diagnosing Alzheimer's
News & Features NPR ·